Pierre Fayad, M.D., will start April 1:

Stroke Expert from Yale University Named Chairman

of UNMC Department of Neurological Sciences

Pierre Fayad, M.D., an expert in stroke and neurovascular disease at

Yale University, has been named Reynolds Centennial Professor and Chairman

of the University of Nebraska Medical Center Department of Neurological

Sciences.

The appointment, which is effective April 1, is subject to approval

of the University of Nebraska Board of Regents. Dr. Fayad, 44, is director

of the Yale Vascular Neurology Program and co-director of the Yale Cerebrovascular

Center.

A native of Lebanon, Dr. Fayad can write and speak fluently in four

languages. He earned his medical degree from the University of Rome in

1983, then completed his internship and neurology residency training at

the State University of New York at Buffalo.

From 1989 to 1991, Dr. Fayad did a fellowship in vascular neurology

and stroke at the Yale University School of Medicine. He was named an instructor

in the Neurology Department at Yale in 1991 and was elevated to assistant

professor in 1992 and associate professor in 1997.

In coming to UNMC, Dr. Fayad takes over a newly structured department

that will allow UNMC to better meet the increased neurological needs of

the state and region, said James Armitage, M.D., dean of the UNMC College

of Medicine. The department has been expanded to encompass neurophysiology,

neuropharmacology and other related areas of the neurosciences.

“Nebraska is one of the leading states in terms of the aging population.

Since many neurological diseases are associated with older age, it’s important

that we provide Omaha and Nebraska with the type of neurological care that

is needed,” Dr. Fayad said. “My goal is to build a stroke program that

will be the jewel of the department, UNMC and the region. With the many

advances in care and research taking place nationally and internationally,

UNMC should be a significant contributor in the advancement of the acute

treatments of stroke and in its prevention.”

In addition to stroke, Dr. Fayad also hopes to elevate the level of

care that UNMC provides for other neurologic ailments, such as epilepsy,

neuromuscular disease, movement disorders, and degenerative brain disorders

like Parkinson’s disease and Alzheimer’s dementia.

An active researcher, Dr. Fayad continues to be a leading investigator

in numerous studies investigating newer treatments of acute stroke. He

has been an active investigator in several trials studying medical, interventional

and surgical treatments for the acute treatment of stroke and its prevention,

including several funded through the National Institutes of Health. He

has more than 50 articles and chapters published in journals and books.

He chairs or serves on several monitoring boards for national and international

multicenter research studies, and he is a committed educator and a frequent

national and international lecturer.

Dr Fayad is an active member of several professional organizations and

is a fellow on the Stroke Council of the American Stroke Association. He

also served as co-chairman for the national media campaign, “Stroke in

America,” through the National Stroke Association.

Y NsEWrbF x